Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial

Saved in:

Bibliographic Details
Journal Title:	International Journal of Cancer
Authors and Corporations:	Janning, Melanie, Müller, Volkmar, Vettorazzi, Eik, Cubas‐Cordova, Miguel, Gensch, Victoria, Ben‐Batalla, Isabel, zu Eulenburg, Christine, Schem, Christian, Fasching, Peter A., Schnappauf, Benjamin, Karn, Thomas, Fehm, Tanja, Just, Marianne, Kühn, Thorsten, Holms, Frank, Overkamp, Friedrich, Krabisch, Petra, Rack, Brigitte, Denkert, Carsten, Untch, Michael, Tesch, Hans, Rezai, Mahdi, Kittel, Kornelia, Pantel, Klaus, Bokemeyer, Carsten, Loibl, Sibylle, von Minckwitz, Gunter, Loges, Sonja
In:	International Journal of Cancer, 145, 2019, 3, p. 857-868
Type of Resource:	E-Article
Language:	English
published:	Wiley
Subjects:	Cancer Research Oncology

Internet